Hormonal
Higher expression of the adipose (adp/WDTC1) gene in human subcutaneous adipose tissue is associated with lower body fat mass and enhanced insulin sensitivity.
This research identifies a specific gene (adp/WDTC1) in fat tissue that correlates with being leaner and more insulin sensitive. While you cannot directly 'dose' this gene, understanding that higher expression is linked to better metabolic health may inform future therapeutic targets for obesity and diabetes management.
Consistent with animal studies, our results suggest that high adp expression in human adipose tissue is associated with lower adiposity and enhanced glucose utilization.
Why this rating
Observational cross-sectional study with moderate sample sizes across three cohorts, but lacks causal proof and mechanistic measurement in humans.
Source
Adipose tissue expression of <i>adipose</i> (WDTC1) gene is associated with lower fat mass and enhanced insulin sensitivity in humans
José E. Galgani et al. · Obesity · 2013
DOI 10.1002/oby.20371
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →